These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6978840)

  • 21. Effect of phorbol myristate acetate (PMA) and ionophore A23187 on interleukin-2 levels and proliferation of activated T lymphocytes from patients with lepromatous leprosy.
    Alfaro-Bustamante F; Ramirez-Flores G; Gonzalez-Mendoza A; Islas-Rodriguez A; Fafutis-Morris M
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):73-9. PubMed ID: 9207756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immortalization of BGDF (BCGF II)- and BCDF-producing T cells by human T cell leukemia virus (HTLV) and characterization of human BGDF (BCGF II).
    Shimizu K; Hirano T; Ishibashi K; Nakano N; Taga T; Sugamura K; Yamamura Y; Kishimoto T
    J Immunol; 1985 Mar; 134(3):1728-33. PubMed ID: 2981920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thymoma production of T cell growth factor (Interleukin 2).
    Farrar JJ; Fuller-Farrar J; Simon PL; Hilfiker ML; Stadler BM; Farrar WL
    J Immunol; 1980 Dec; 125(6):2555-8. PubMed ID: 6968789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inducible lymphokines of T cell tumors.
    Corley RB; Dexter CM; Ovnic M
    Crit Rev Immunol; 1986; 6(1):71-103. PubMed ID: 3522104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2.
    Gimmi CD; Freeman GJ; Gribben JG; Sugita K; Freedman AS; Morimoto C; Nadler LM
    Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6575-9. PubMed ID: 1650475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of IL 1-dependent and IL 1-independent T cell lines by calcium ionophore and phorbol ester.
    Zlotnik A; Daine B
    J Immunol; 1986 Feb; 136(3):1033-7. PubMed ID: 3079793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and characterization of a B cell growth inhibitory factor (BIF) on BCGF-dependent B cell proliferation.
    Kawano M; Iwato K; Kuramoto A
    J Immunol; 1985 Jan; 134(1):375-81. PubMed ID: 3871108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Signals involved in T cell activation. I. Phorbol esters enhance responsiveness but cannot replace intact accessory cells in the induction of mitogen-stimulated T cell proliferation.
    Davis L; Lipsky PE
    J Immunol; 1985 Nov; 135(5):2946-52. PubMed ID: 3876369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phorbol myristate acetate and in vitro T lymphocyte function. I. PMA may contaminate lymphokine preparations and can interfere with interleukin bioassays.
    Orosz CG; Roopernian DC; Bach FH
    J Immunol; 1983 Apr; 130(4):1764-9. PubMed ID: 6403611
    [No Abstract]   [Full Text] [Related]  

  • 30. Production of macrophage activating factor by human leukemic T cell lines.
    Imai K; Suzuki Y; Harada T; Morikawa S; Tanaka A
    Microbiol Immunol; 1985; 29(8):769-81. PubMed ID: 3906371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The AKR thymoma BW5147 is able to produce lymphokines when stimulated with calcium ionophore and phorbol ester.
    Hagiwara H; Yokota T; Luh J; Lee F; Arai K; Arai N; Zlotnik A
    J Immunol; 1988 Mar; 140(5):1561-5. PubMed ID: 3126229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of phorbol myristate acetate on T cell colony formation, interleukin-2 (IL-2) receptor expression and IL-2 production by cells from patients at all stages of HIV infection.
    Allouche M; Lunardi-Iskandar Y; Varela-Millot C; Itzhaki M; Cornuet P; Meyer P; Jasmin C; Georgoulias V
    Clin Exp Immunol; 1990 Aug; 81(2):200-6. PubMed ID: 1696861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phorbol myristate acetate (PMA) reverses inhibition of interleukin-2 production by T lymphocytes of patients with systemic lupus erythematosus.
    Sierakowski S; Kucharz EJ
    Med Interne; 1988; 26(1):67-73. PubMed ID: 3261032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. There is no correlation between function and lymphokine production of HBs-antigen-specific human CD4(+)-cloned T cells.
    Tsutsui H; Mizoguchi Y; Morisawa S
    Scand J Immunol; 1991 Oct; 34(4):433-44. PubMed ID: 1718026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of T-cell-derived factors with the use of B-prolymphocytic leukemia cells.
    Sauerwein RW; van der Meer WG; Logtenberg T; Aarden LA
    Clin Immunol Immunopathol; 1988 Jan; 46(1):1-13. PubMed ID: 3257174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Signal requirement for interleukin-1-dependent interleukin 2 production by a human leukemia-derived HSB.2 subclone.
    Mukaida N; Kasahara T; Yagisawa H; Shioiri-Nakano K; Kawai T
    J Immunol; 1987 Nov; 139(10):3321-9. PubMed ID: 3500216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Independent regulation of B-cell inducing factor and IL-2 production by T lymphocytes, and direct and indirect promotion of immunoglobulin secretion by glucocorticosteroid.
    Jeong G; Nakoinz I; Ralph P
    Cell Immunol; 1986 Nov; 103(1):199-206. PubMed ID: 3492284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Lymphokine production using IL-2-dependent human T-lymphocytes].
    Stecher A; Mohr H; Schügerl K
    Beitr Infusionther Klin Ernahr; 1987; 18():292-4. PubMed ID: 3125831
    [No Abstract]   [Full Text] [Related]  

  • 39. Regulation of interleukin-2 synthesis in human thymocytes.
    Reem GH; Cook LA; Palladino MA
    J Biol Response Mod; 1984; 3(2):195-205. PubMed ID: 6610023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T cell growth factor from human splenic cell cultures: conditions for its production, and its utilization for maintenance of cytotoxic T cell lines.
    Tanaka Y; Sugamura K; Hinuma Y
    Microbiol Immunol; 1981; 25(10):1077-86. PubMed ID: 6273698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.